First Trust NYSE Arca Biotechnology Index Fund Rating $208.48 +0.23 (+0.11%) Closing price 04:10 PM EasternExtended Trading$208.45 -0.03 (-0.02%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.66Holdings in FBT have an aggregate rating of Moderate Buy based on 429 analyst ratings issued in the past year covering 25 companies (84.4% of the portfolio).FBT Aggregate Price Target$208.48High Prediction$208.48Average Prediction$208.48Low Prediction$208.48Holdings in FBT have an aggregate price target of $208.48 and a range of $208.48 to $208.48 covering 25 companies (84.4% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.65%BNTXBioNTech$95.50-3.9%4.1137 of 5 stars2.72$133.13 39.4%18News CoveragePositive NewsEarnings ReportGap Down3.64%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6361 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings3.62%ADMAADMA Biologics$10.25-0.6%4.765 of 5 stars2.83$25.67 150.4%6Trending NewsUpcoming EarningsAnalyst Downgrade3.57%CORTCorcept Therapeutics$51.37-0.5%4.3822 of 5 stars2.50$74.67 45.4%8Earnings ReportAnalyst ForecastAnalyst Revision3.53%BIIBBiogen$189.13+1.0%3.8003 of 5 stars2.50$214.23 13.3%28Earnings ReportAnalyst Upgrade3.48%VCYTVeracyte$32.97-1.4%2.4978 of 5 stars2.38$43.83 32.9%8News CoverageEarnings Report3.46%ILMNIllumina$139.07-0.2%3.0776 of 5 stars2.22$131.06 -5.8%18Earnings ReportAnalyst Forecast3.46%NTRANatera$206.77-2.3%4.1795 of 5 stars2.79$253.47 22.6%19Upcoming Earnings3.42%KRYSKrystal Biotech$284.57-0.8%3.4454 of 5 stars2.83$324.11 13.9%12Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.41%NEONeoGenomics$8.86-1.6%2.63 of 5 stars2.38$13.86 56.4%13Earnings Report3.40%EXELExelixis$44.42+0.6%3.3604 of 5 stars2.39$47.00 5.8%23Positive NewsEarnings Report3.39%BRKRBruker$38.01+4.5%3.4975 of 5 stars2.47$49.38 29.9%15Upcoming Earnings3.39%TECHBio-Techne$56.68+3.5%4.2711 of 5 stars2.71$72.77 28.4%14Positive NewsUpcoming EarningsGap Up3.36%AXSMAxsome Therapeutics$223.06-0.3%3.17 of 5 stars2.90$251.89 12.9%21Trending NewsEarnings ReportAnalyst Forecast3.33%RGENRepligen$125.61+6.3%3.859 of 5 stars2.86$168.75 34.3%14Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume3.27%NBIXNeurocrine Biosciences$135.06+0.7%4.3717 of 5 stars2.82$180.45 33.6%223.25%ALKSAlkermes$36.25+6.1%3.818 of 5 stars2.82$44.29 22.2%17Trending NewsGap Up3.24%ONCBeOne Medicines$297.49+0.1%4.4234 of 5 stars2.71$390.58 31.3%14News CoveragePositive NewsUpcoming EarningsAnalyst Forecast3.24%HALOHalozyme Therapeutics$65.87+2.0%4.2853 of 5 stars2.42$79.11 20.1%12Upcoming EarningsInsider Trade3.23%INCYIncyte$97.47+0.3%4.0887 of 5 stars2.43$104.26 7.0%21Earnings ReportAnalyst Forecast3.22%UTHRUnited Therapeutics$572.20-1.6%3.5587 of 5 stars2.77$601.50 5.1%13Upcoming EarningsInsider Trade3.22%VRTXVertex Pharmaceuticals$424.36-1.3%4.6035 of 5 stars2.83$554.83 30.7%29Trending NewsEarnings ReportAnalyst DowngradeInsider Trade3.20%REGNRegeneron Pharmaceuticals$702.45-1.0%4.528 of 5 stars2.77$826.59 17.7%26Earnings ReportDividend AnnouncementAnalyst Upgrade3.19%BMRNBioMarin Pharmaceutical$53.24-4.0%4.5105 of 5 stars2.77$90.32 69.6%22Trending NewsAnalyst Forecast3.18%ARGXargenex$794.70-2.0%3.908 of 5 stars2.92$1,016.22 27.9%24Upcoming Earnings This page (NYSEARCA:FBT) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
